Amy Klobuchar actually said...

"So that is why we were coming up, Senator Grassley and I, with a way to sort of even the playing field."

"Let's be very clear about what these deals are all about."

"allows operating companies to exploit the lack of transparency in patent ownership to win a tactical advantage that could not be gained with a direct attack."

"it is entirely proper to put the burden on the drug companies to demonstrate that actually these have a pro-competitive, not anti-competitive impact."